hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet
RxNorm concept 1050323, clinical dose form (scdf).
- RxCUI
- 1050323
- Term type
- Clinical dose form (SCDF)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1050323 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- Oral Tablet (DF, has dose form)
- methenamine (IN, has ingredient)
- methylene blue (IN, has ingredient)
- hyoscyamine (IN, has ingredient)
- sodium phosphate, monobasic (IN, has ingredient)
- hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet [Urogesic Blue Reformulated Apr 2012] (SBDF, has tradename)
- hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet [Uro-Blue] (SBDF, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1050323 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1050323 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1050323. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.